0 NASDAQ Companies - January 10, 2025Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on January 10, 2025, […]Read More
0 NASDAQ Companies - January 10, 2025Freight Technologies Announces Unaudited Financial Results for the Six Months Ended June 30, 2024HOUSTON , Jan. 10, 2025 (GLOBE NEWSWIRE) — Freight Technologies, Inc. (Nasdaq: FRGT) (“Fr8Tech” or “Freight Technologies” or the “Company”), […]Read More
0 NASDAQ Companies - January 10, 2025Eagle Bancorp, Inc. Announces Extension of Registered Exchange Offer for its Outstanding 10.00% Senior Notes due 2029BETHESDA, Md., Jan. 10, 2025 (GLOBE NEWSWIRE) — Eagle Bancorp, Inc. (NASDAQ: EGBN) (“Eagle”) today announced that (i) the expiration […]Read More
0 NYSE Companies - January 10, 2025Matinas BioPharma Receives NYSE Noncompliance NoticeBEDMINSTER, N.J. , Jan. 10, 2025 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) announces that on January […]Read More
0 NASDAQ Companies - January 10, 2025Delisting of Securities of BIMI International Medical Inc.; The Dixie Group, Inc.; Clover Leaf Capital Corp.; Focus Impact BH3 Acquisition Company; Forza X1, Inc.; Vertex Energy, Inc; Slam Corp.; and HHG Capital Corporation from The Nasdaq Stock MarketNEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) — The Nasdaq Stock Market announced today that it will delist the common stock of BIMI […]Read More
0 TSX Venture News - January 10, 2025Change of Directors at Lumine GroupTORONTO, Jan. 10, 2025 (GLOBE NEWSWIRE) — Lumine Group Inc. (“Lumine Group”) (TSXV:LMN) announced today the resignation of Robin van […]Read More
0 TSX News - January 10, 2025Interfor Completes Divestiture of Québec OperationsBURNABY, British Columbia, Jan. 10, 2025 (GLOBE NEWSWIRE) — INTERFOR CORPORATION (“Interfor” or the “Company”) (TSX: IFP) announced today that […]Read More
0 NASDAQ Companies - January 10, 2025Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)WALTHAM, Mass., Jan. 10, 2025 (GLOBE NEWSWIRE) — Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing […]Read More
0 NASDAQ Companies - January 10, 2025Photronics Appoints Executive ChairmanBROOKFIELD, Conn., Jan. 10, 2025 (GLOBE NEWSWIRE) — Photronics, Inc. (Nasdaq: PLAB), a worldwide leader in photomask technologies and solutions, […]Read More
0 NASDAQ Companies - January 10, 2025Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)ALACHUA, Fla. and TAMPA, Fla., Jan. 10, 2025 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing […]Read More